srt2104
AssetSmall molecule
Small-molecule activator of sirtuin 1 (SIRT1).
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Mitochondrial biogenesis (PGC-1α)
- Indications
- 3
- Trials
- 6
- Developers
- 2
Indications
3Chronic obstructive pulmonary disease
Phase 1COMPLETEDNCT00920660clinicaltrials.gov7 Oct 2026
Type 2 diabetes
Phase 1COMPLETEDNCT01031108clinicaltrials.gov7 Oct 2026
Ulcerative colitis
Phase 1COMPLETEDNCT01453491clinicaltrials.gov7 Oct 2026
- Targets and what it contains5
- Owner and partners2
- Trials6
- Evidence for its targets5
- Competitors12
- Aging relevance3
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 5 sources